|
For information on all types of cancers, including related risk factors, prevention, diagnosis, and treatment, click on the links below.
- The National Cancer Institute or NCI is the federal government’s major cancer research and training agency.
- The American Cancer Society is a nationwide, community-based voluntary health organization with many regional divisions and more than 3,400 local offices.
- The Leukemia and Lymphoma Society is the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services.
Clinical trials lead to new and improved ways to prevent, diagnose, and treat cancer. Scientists and physicians at the University of Illinois at Chicago engage in a variety of cancer clinical trials to improve cancer outcomes, such as survival, side effects and quality of life for cancer patients.
- Information about clinical trials available at UIC can be obtained by calling the Clinical Trials Research Office at 312-413-4826.
- For information about the Lycopene Prostate Cancer Prevention Study, call 312-413-5867.
The University of Illinois Medical Center offers state-of-the-art facilities, cutting edge technology and drug therapies, and a faculty of world-renowned physicians and scientists. The cancer program is approved by the American College of Surgeons Commission on Cancer.
The Familial Gastrointestinal Cancer Unit (FGICU) of the University of Illinois at Chicago is the only facility in Chicago that specializes in gastrointestinal cancer genetics. A multidisciplinary team provides comprehensive state-of-the-art care for all members of families who have a high risk for developing gastrointestinal or other types of related cancers because of an inherited predisposition.
The Walter Payton Liver Center offers coordinated and integrated care to liver cancer patients by a team of physicians with expertise in medical oncology, hepatology, surgical oncology, interventional radiology, and transplant surgery. This clinic is linked to a robust group of researchers who study molecular mechanisms that lead to the development of liver cancer.
The University of Illinois at Chicago is the only institution in the state of Illinois participating in the MPD-Research Consortium. This international consortium has funding from the National Cancer Institute to develop new research projects and clinical trials for patients diagnosed with myeloproliferative neoplasms, such as polycythemia vera, essential thrombocythemia, or primary myelofibrosis. Several clinical trials are already open and new trials will be opened within a few months. For more information, please contact Dr. Damiano Rondelli at 312-996-6179 or drond@uic.edu.
The UIC Neuro-Oncology Program offers brain tumor patients advanced state-of-the-art care from a multidisciplinary healthcare team. Members include neuro-oncologists, neurosurgeons, neuro-radiologists, radiation therapists, neurologists, neuro-psychologists, neuropathologists, and nurses. UIC is the leading site for the NovoCure recurrent glioblastoma study and will soon begin a NovoCure study in newly diagnosed glioblastoma patients. The neuro-oncology clinical program is linked to a research program that includes the most powerful MRI available for human imaging, brain tumor epidemiology, genetics underlying neurocarcinogen risks and outcomes for brain tumors, creating new ways to transport treatment to treat brain tumors, and a brain tumor vaccine trial.
|
|